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Highlights  
Arc/Arg3.1 plays a key role in controlling synaptic strength and AMPA receptor endocytosis 
Interactions between Arc and the CME machinery place Arc as a decisive regulator of 
AMPAR trafficking 
The Arc-CME pathway targets specific GluA subunits for endocytosis as identified by a 
number of experimental approaches including rectification of AMPAR currents. 
Disruption of the Arc-CME pathway in neurological diseases and as a potential therapeutic 
target to normalise AMPAR expression   
 
Abstract  
The activity-regulated cytoskeleton associated protein (Arc/Arg3.1) plays a key role in 
determining synaptic strength through facilitation of AMPA receptor (AMPAR) endocytosis. 
Although there is considerable data on the mechanism by which Arc induction controls 
synaptic plasticity and learning behaviours, several key mechanistic questions remain. Here 
we review data on the link between Arc expression and the clathrin-mediated endocytic 
pathway which internalises AMPARs and discuss the significance of Arc binding to the 
clathrin adaptor protein 2 (AP-2) and to endophilin/dynamin. We consider which AMPAR 
subunits are selected for Arc-mediated internalisation, implications for synaptic function and 
consider Arc as a therapeutic target.   
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Introduction  
Fast glutamatergic synaptic transmission, through the activation of ionotropic AMPARs, is 
one of the major mechanisms of neuronal communication in the mammalian brain. AMPARs 
located within the postsynaptic membrane are tetrameric in structure and consist of a 
homomeric or heteromeric combination of 4 known subunits (GluA1-4). The mRNA coding 
for the GluA2 subunit undergoes post-transcriptional editing, with a single amino-acid 
changed from glutamine (Q) to arginine (R). This is called Q/R editing, with AMPAR 
containing GluA2(Q) permeable to calcium whilst GluA2(R) containing receptors 
impermeable. The great majority of the GluA2 subunits expressed in the central nervous 
system is in the GluA2(R) form and in mature pyramidal neurons of the hippocampus a 
significant proportion of AMPAR present at the synapses are composed of GluA1 and GluA2 
subunit heterodimers. Therefore it is probable that a large number of calcium impermeable 
AMPARs are present at the cell surface. The subunit composition of AMPAR not only 
determines Ca2+ permeability but also determines kinetics, rectification and receptor 
trafficking dynamics thus precisely tuning receptor properties to specific synaptic 
requirements (recently reviewed in [1,2]). 
The trafficking of AMPARs in and out of the synaptic membrane is a highly dynamic process 
which is regulated during development, during synaptic plasticity and can be impaired during 
disease processes [3,4]. Although there are several mechanisms underlying the trafficking of 
AMPARs, one of the most studied involves the immediate gene product Arc/Arg3.1 coupling 
synaptic activity to the endocytosis of AMPARs. Following neural activity (such as high 
frequency stimulation or seizure activity) or exposure to BDNF, Arc/Arg3.1 mRNA is rapidly 
trafficked to postsynaptic dendritic sites and then translated leading to AMPA receptor 
endocytosis [5-8]. Arc is involved in specific forms of synaptic plasticity which include 
homeostatic scaling and LTP (discussed in other reviews in this special issue) and Arc 
expression is induced by group 1 metabotropic glutamate receptor (mGluR) activation 
resulting in AMPA receptor endocytosis leading to long term depression (mGluR-LTD) [7]. 
The effects of inducing mGluR-dependent LTD can be mimicked by overexpression of Arc 
protein in neurons which reduces the surface expression of specific GluA subunits [7]. 
Deletion of Arc or inhibition of its synthesis prevents AMPA receptor endocytosis, increases 
surface AMPARs expression and blocks mGluR-LTD. The importance of Arc in synaptic 
plasticity has been illustrated by reducing Arc expression in rodents, resulting in 
disturbances in cognitive function including impaired memory consolidation [9-12].  
Although there has been extensive progress in understanding the molecular mechanisms 
underlying the actions of Arc and its role in synaptic plasticity, many questions still remain 
unanswered. In this review we will discuss three related questions:  
1) How is Arc linked to the endocytic machinery that internalises AMPARs?  
2) Does Arc selectively target specific subunits of AMPAR for endocytosis? 
3) Arc as a potential target to manipulate AMPAR trafficking defects in disease states?  
 
1. What links Arc expression to the internalisation of AMPARs during synaptic 
plasticity? 
Over the last decade there have been major advances in mapping the mechanism by which 
activity-dependent activation of Arc expression regulates AMPAR trafficking [10,13]. It is well 
established that the internalisation of AMPARs from synapses is mediated by the clathrin-
mediated endocytic pathway (CME) [14-18]. The first evidence that Arc-mediated 
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internalisation of AMPARs occurs through the CME pathway came from experiments 
showing that Arc interacts with endophillin and dynamin [19].  
Endophilin and dynamin are accessory proteins of the CME machinery that are required for 
membrane constriction and scission of the clathrin-coated vesicle containing the cargo that 
is to be internalised (in this case AMPARs). Neither endophilin nor dynamin appear to 
participate in the cargo selection process as they are only involved in late phases within the 
sequential events of CME. Dynamin is recruited at late stages of endocytosis and its 
enrichment coincides with neck fission and release of the vesicle [20, 21]. Supporting the 
idea that endophilin is only recruited at late stages of the endocytosis process is the 
observation that the assembly and maturation of clathrin-coated pit formation still occurs in 
cortical neurons obtained from mice where distinct endophilins have been deleted [22]. 
These findings demonstrate that assembly and early maturation events are independent of 
endophilin. Therefore an interaction between Arc with either endophillin or dynamin may 
enhance the processes of vesicle budding and the scission of the vesicle neck but it does 
not place the Arc-endophillin/dynamin interaction as decisive in the selection and targeting of 
AMPARs for internalisation.  
Recently, da Silva et al. (2016) [23] used specific anti-Arc antibodies to immunoprecipitate 
endogenous Arc protein from hippocampal homogenised lysate to identify novel Arc binding 
partners. Using this approach they identified different subunits of the adaptor protein 
complex-2 (AP-2) as endogenous binding partners of Arc, including the two  adaptin 
isoforms:  also known as A and 2, also known as C as well as the 2 and μ2 isoforms 
[23]. In contrast to the late role of dynamin and endophilin in mediating clathrin-mediated 
endocytosis, the AP-2 complex plays a critical role in initiating this process, as it coordinates 
cargo recruitment and selection together with clathrin recruitment to the plasma membrane 
(Figure 1,[ 24-27]).  
To demonstrate that the Arc/AP-2 interaction is required for the endocytosis of AMPARs, da 
Silva et al (2016) [23] expressed in hippocampal neurons an Arc mutant construct, which 
cannot bind to the AP-2 complex, and showed that this blocks the Arc-dependent reduction 
in the AMPAR-mediated miniature excitatory postsynaptic current (mEPSC) amplitude 
[23,28]. This Arc-mediated effect is specific to AMPAR subunits as the internalization of EGF 
receptors is unaffected by expression of either Arc-WT or Arc mutant that do not bind to AP-
2 [23]. Furthermore, da Silva et al. showed that expression of Arc-WT in hippocampal 
neurons reduces the proportion of synaptic AMPARs that lack the GluA2 subunit, an effect 
that is impaired in neurons expressing the Arc mutant that cannot bind the AP-2 complex 
[Figure 2; 23]. This finding was unexpected as the AP-2 complex has been shown to directly 
interact with high affinity to the GluA2 subunit but only weakly with GluA1 subunits [29]. 
However it is possible that other proteins interact with GluA1 subunits and then interact with 
the AP2-complex. An example of such a possible candidate protein is Huntingtin interacting 
protein 1 (HIP1) which is a component of clathrin-coated vesicles and co-localises with AP-2 
[30]. In neurons obtained from HIP1–/– mice there is a profound defect in clathrin-mediated 
internalization of GluA1-containing AMPARs [30]. The observation that Arc directly binds to 
AP-2 provides an additional step to elucidate the mechanistic link between activity-
dependent expression of Arc and the endocytosis of AMPAR subunits (Figure 1). 
 
Thus current evidence indicates that Arc interacts with both AP-2 and with 
dynamin/endophillin. The role of these Arc interactions in coordinating GluA1 internalisation 
and their sequence within the CME pathway requires discussion. In particular, are both of 
these interactions or either of them alone required for Arc-mediated endocytosis? Firstly it is 
important to note that AP-2 and dynamin bind Arc at the same aa sequence motif, whereas 
endophilin binding site is situated in an independent location, which further complicates 
interpretation of experimental data. Thus the Arc mutant construct that does not bind AP-2 
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will also be unable to bind dynamin. To address this da Silva et al., [23] designed short 
hairpin RNA sequences to knockdown endogenous AP-2 in hippocampal cultures. In AP-2 
depleted neurons, overexpression of Arc-WT failed to internalise AMPARs. To further 
demonstrate that Arc-AP-2 is required for AMPAR endocytosis, the authors expressed in the 
same lentivirus vector Arc-WT and short hairpin RNA to knockdown endogenous AP-2-
emGFP-tagged, and used another lentivirus vector to express AP-2-mCherry-tagged. These 
two constructs were then co-expressed in the hippocampal neurons to address whether re-
introduction of AP-2 in a depleted background would rescue the Arc-mediated endocytosis of 
AMPAR. Indeed, re-insertion of AP-2 was sufficient to rescue the Arc-WT mediated 
endocytosis of AMPAR, an effect that was blocked in cells expressing an Arc-mutant that 
cannot bind to AP-2. In these experiments endogenous dynamin and endophilin are present 
and were clearly insufficient to promote the internalization of AMPAR in the absence of AP-
2. A model integrating the temporal sequence of clathrin-mediated endocytosis events may 
explain these findings. It is reasonable to propose that upon an increase in neural activity, 
newly expressed Arc first binds AP-2 to initiate the endocytosis process by simultaneously 
recruiting clathrin to the plasma membrane and by selecting the cargo (AMPAR) to be 
internalised. Once this process is underway the affinity between Arc and AP-2 reduces 
leading to the dissociation between Arc and AP-2. This makes the Arc binding domain 
available to dynamin. Arc-dynamin binding would then initiate/enhance dynamin 
polymerization and scission of the vesicle neck containing the AMPARs (see Figure 1). This 
proposed model is supported by the observation that dynamin polymerization, its GTPase 
activity and dynamin assembled stability are all enhanced in presence of Arc using in vitro 
assays [31].   
The Arc interaction motif that binds to endophilin is not in close proximity to the interacting 
motifs for AP-2 and dynamin and thus it should be available to binding Arc at any stage of 
the CME process. Functional experiments have demonstrated that internalisation of GluA1 is 
significantly reduced in the absence of AP-2 even though endophilin is still present [23]. 
Conversely, when the interaction between Arc and endophilin is absent and the Arc-AP-2 
interaction is intact endocytosis of GluA1 is inhibited [19]. The simplest explanation for these 
observations is that both interactions are required to internalise GluA1 with the Arc-
endophilin interaction occurring downstream to the Arc-AP-2 interaction. Other possible 
explanations are that: a) Arc-mediates a clathrin-independent, but endophilin dependent 
form of endocytosis and b) the truncated form of Arc, where 10 amino acids are deleted at its 
N-terminal (to block endophilin binding [19]), compromise its abilities to bind to other 
partners and therefore non-specifically disrupts AMPAR endocytosis.  
Taken together these observations suggest that the Arc interaction with AP-2 is required for 
targeting GluA1 containing receptors to the CME pathway and that dynamin and potentially 
endophilin play a critical role in coordinating the efficiency by which synaptic GluA1 
containing AMPARs are internalised. However more investigation is required to clarify the 
precise mechanism by which Arc coordinates AMPAR endocytosis.  
2. Does Arc target specific AMPA receptor subunits to endocytosis?  
The findings that Arc controls excitatory synaptic transmission by decisively selecting AMPA 
receptors to be internalised raises an important question: which of the GluA subunits are 
targeted for internalisation by Arc-mediated endocytosis? Is there any specificity or can any 
of the four subunits (GluA1-4) be internalised? This is an important question as the targeting 
of specific receptor subunits for internalisation could alter the balance of the remaining 
synaptic receptors, changing synaptic dynamics, Ca2+ permeability and plasticity. Before 
considering this question, it is necessary to firstly define the subunit composition of synaptic 
AMPARs. In the adult hippocampus, there are two major forms of synaptic AMPARs: 
heteromers of GluA1 and GluA2 and heteromers of GluA2 and GluA3 with a small proportion 
of GluA1 homomeric receptors (less than 10 % [32]). The relative proportions of the 
heteromeric receptors is still open to debate with some studies suggesting they are of 
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roughly equal abundance while a recent single cell deletion study suggested 80% of 
receptors contain GluA1 and 2 subunits (reviewed in Henley and Wilkinson, 2016 [1]). At 
immature synapses the expression of GluA2 is low and increases rapidly during the first 
postnatal week [33, 34]. Because of the difficulty in studying Arc-mediated endocytosis of 
AMPAR in vivo and in acute slices, many studies have used primary hippocampal neuronal 
cultures instead, as the neurons are easy to transfect and manipulate. Here the composition 
of synaptic AMPARs is dependent on the age of the pups used to prepare the cultures 
(embryonic versus postnatal) and how long the cells have been cultured before they are 
used. For example, Pickard et al (2000) [35] showed that in primary hippocampal cultures 
(from 3-5 day old rat pups) only 67% of GluA1–4-positive puncta contain GluA2 
immunoreactivity after 3-5 days in cultures. This ratio increases with time in culture, so that 
after 14 days, co-localization was almost complete with ~ 96% of GluA1-4 puncta containing 
GluA2 [35]. However, the precise subunit composition of synaptic receptors in neuronal 
culture still remains unclear (i.e. the proportion of heteromeric/homomeric receptors). 
Another model system used to study the mechanism by which Arc regulates synaptic 
AMPARs is the organotypic hippocampal slice, which has a more complete neuronal 
architecture, compared to neuronal cultures, and can be transfected unlike acute slices. The 
subunit composition of synaptic AMPARs in organotypic slices is unclear, although receptors 
show little rectification (see section below) consistent with few GluA2 lacking receptors 
[36,37]. Potential differences in AMPAR subunit composition between adult brain (and acute 
slices), primary cultures and organotypic slice culture can potentially complicate the 
interpretation of data on which of the GluA subunits are selected for internalisation following 
induction of Arc expression (see below).  
A number of different experimental techniques have been used to determine the selectivity 
of Arc-endocytosis for specific GluA subunits. Surface and/or internalised AMPARs can be 
biotinylated and then blotted against antibodies specific for the various GluA subunits (Figure 
2 A,B). This allows measurement of the ratio of internalised to surface AMPA receptor 
subunits. Surface AMPARs can also be directly labelled using specific antibodies targeted to 
the extracellular N-terminus sequences. The major disadvantage of these labelling 
techniques is a lack of specificity for synaptic receptors as extra-synaptic receptors will also 
be labelled.  
A second approach is to use electrophysiological recordings to measure the degree of 
AMPAR rectification, AMPAR are isolated by blocking both NMDA and GABAA receptors. 
Here the amplitude of either AMPAR-mediated miniature excitatory post synaptic currents 
(EPSCs) or evoked EPSCs is measured at two different holding potentials (usually -60 and + 
40 mV, illustrated in Figure 2C-E). The amount of current passed through the AMPARs at 
the different holding currents depends on receptor subunit composition. If the AMPARs lack 
GluA2 subunits, then they can be blocked in a voltage-dependent manner by a class of 
molecules called polyamines (spermine is normally added to the patch pipette solution). When 
the neuron is at a depolarized membrane potential (+ 40 mV), the polyamines block the AMPAR 
channel more strongly, preventing the passage of ions through the channel. Thus GluA2-lacking 
AMPARs are said to be inwardly rectifying which means that they pass less outward current than 
inward current ([38-42]; Figure 2C,D). In contrast, receptors containing edited GluA2 subunits 
have a linear current-voltage relationship [43, 44]. The amount of rectification is quantified by 
the rectification index which is the ratio of the AMPAR-mediated current amplitude at the 
depolarised potential relative to the current amplitude at the hyperpolarised potential (Figure 
2E). The rectification index is a little counter-intuitive as an increase in the rectification index 
means there is less rectification. In the adult hippocampus, CA1-CA3 synapses have a high 
rectification index, as most receptors contain edited GluA2 [45]. In hippocampal cultures, the 
rectification index maybe lower as the GluA2 subunit may not be expressed at all synapses 
depending on the age of the culture [35].  
To determine whether Arc preferentially targets specific AMPAR subunits for endocytosis 
both AMPA receptor surface labelling and electrophysiological recordings have been used in 
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combination with either Arc overexpression or knockdown and the use of a chemical protocol 
to induce Arc protein expression. It is well-established that exposure of the group I 
metabotropic receptor agonist (DHPG) induces mGluR-LTD in cultured hippocampal 
neurons and in acute hippocampal slices [46,47]. This form of synaptic plasticity is Arc-
dependent [7].  
There is substantial evidence, that in primary neuronal cultures, Arc mediates the 
internalisation of GluA1 subunits. For example, Chowdhury et al (2006) [19], Shepherd et al 
(2006) [28] and Waung et al (2008) [7] all showed that changes in Arc expression could 
either reduce the surface expression of GluA1 subunits (with Arc overexpression) or 
increase GluA1 surface expression (with Arc knockdown). Waung et al (2008) [7] additionally 
showed that Arc overexpression occludes the mGluR-induced (DHPG) decrease in surface 
GluA1 expression. In an interesting study, Peebles et al (2010) [48] showed that Arc not only 
mediates GluA1 endocytosis but also regulates changes in spine morphology. Two further 
studies [49, 50] have modified Arc expression indirectly, by targeting the enzymes that 
ubiquitinate Arc, and have showed changes in surface GluA1 subunit expression consistent 
with the alterations in Arc metabolism and protein expression.    
Taken together this data provides strong evidence that GluA1 is internalised via Arc-
mediated endocytosis in neuronal cultures. As previously mentioned, at mature hippocampal 
synapses, most GluA1 is combined with GluA2 in heteromeric receptors with little GluA1 
present in the form of homomeric receptors [32]. Thus it would be expected that GluA2 
would also be internalised by Arc. However, contrary to expectations, there is little or no 
accompanied change in the expression of GluA2 subunits in neuronal cultures. For example, 
Shepherd et al (2006) [28] reported that surface levels of GluA2 remain unchanged even 
though GluA1 surface expression is significantly decreased by Arc overexpression. Eales et 
al (2014)[47] showed that application of DHPG to hippocampal cultures induces endocytosis 
of GluA1 subunits, increases the rectification index of mEPSC amplitudes but does not 
internalise GluA2 subunits. More recently da Silva et al (2016) [23] showed that Arc 
overexpression facilitates the internalisation of expressed GluA1 subunits but not GluA2 
subunits in H4 neuroglioma cell lines (Figure 2 A,B). Furthermore they showed in primary 
hippocampal neuronal cultures that overexpression of Arc increased the rectification index 
which is consistent with a preferential loss of GluA1 containing receptors [23; Figure 2F,G].   
If GluA1 is internalised by Arc-mediated endocytosis, why do GluA2 surface levels remain 
unchanged? The increase in rectification index [23,47] is consistent with a preferential loss of 
GluA1 homomeric receptors leaving a higher proportion of AMPA receptors containing 
GluA2 at synapses. Thus the simplest explanation for these observations is that neuronal 
cultures express a higher proportion of GluA1 homomeric receptors compared to the amount 
found in the adult hippocampus. A recent study by Takemoto et al (2017) [51] supports this 
proposal. They showed that optically inactivating GluA1 or by applying an agent (NASPM) 
which blocks AMPARs lacking the GluA2 subunit reduced the AMPAR-mediated synaptic 
currents to ~50% in hippocampal primary cultures, indicating that approximately half of the 
AMPAR-mediated synaptic current was mediated by GluA1 homomeric receptors. They 
suggest that high levels of spontaneous activity in primary cultures can drive GluA1 into 
synapses increasing the level of synaptic GluA1 homomeric receptors [51,52]. Because the 
single-channel conductance is about four times greater in GluA2-lacking AMPARs than in 
GluA2-containing ones [53], even the removal of a small fraction of GluA1 homomeric 
receptors at synapses via Arc-facilitated endocytosis could be responsible for a relatively 
large reduction in the synaptic AMPAR-mediated current.  
Rial Verde et al (2006) [54] investigated the actions of Arc in organotypic hippocampal slice 
cultures (prepared from 5-7 day old rats and cultured for 6-9 days). They reported that, in 
contrast to neuronal culture studies, AMPAR composed by GluA2/3 subunits are 
preferentially targeted for internalisation by Arc. They first showed that when Arc was over-
expressed (using Sindbis virus) AMPAR-mediated evoked EPSCs and miniature EPSCs 
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were reduced in amplitude. They then used two approaches, firstly they expressed the 
GluA2 c-terminus tail peptide which prevents the synaptic delivery of GluA2/3 receptors and 
also reduces basal synaptic transmission.  When Arc was co-expressed with the GluA2-c tail 
peptide there was no further depression in surface receptor expression consistent with Arc 
preferentially internalising GluA2 subunits [54]. They also co-expressed Arc with pepAP-2, a 
peptide which prevents the interaction between GluA2 and the AP-2 complex. This abolished 
the Arc mediated reduction in AMPAR-mediated currents [54]. Finally they performed 
biotinylation experiments in hippocampal cultured slices overexpressing Arc to show no 
change in surface GluA1 expression but a reduction in GluA2 surface expression levels [54].  
Why are there such striking differences in the results produced using organotypic slice 
cultures and dissociated neuronal cultures? This is currently unclear. It has been suggested 
that differences in the speed of receptor recycling between cultured neurons versus 
organotypic slice cultures may change the selectivity of Arc for GluA subunits [54]. It has 
been proposed that in organotypic hippocampal slices the recycling of GluA1/2 receptors is 
slow compared to GluA2/3 containing receptors. Thus GluA2/3 receptors are preferentially 
internalised. In contrast the recycling of GluA1/2 is much faster in primary neuronal cultures. 
If this is correct then Arc selectivity is determined by the availability of the receptor pool for 
recycling [54].  
However, the main unanswered question is which molecules mediate Arc selection of 
AMPAR subunits to endocytosis in vivo. 
Data from neuronal cultures and organotypic hippocampal slices suggest that either GluA1 
or GluA2 can be endocytosed by Arc. This suggests that there is nothing specific to the 
subunit sequence but instead targeting may instead just depend on subunit availability [54]. 
However this does not fit with the data from da Silva et al. (2016) [23] who showed that 
GluA2 subunits were not internalised with Arc co-expression although GluA1 subunits were. 
It could be argued that organotypic slices provide a more accurate representation of the in 
vivo brain than neuronal cultures, since neuronal architecture is more complete. However 
the lack of afferent connections to neurons within cultured slices, combined with the loss of 
efferent connectivity to areas outside the slice elicits a reorganization and expansion of 
intrinsic axons [55]. This over connectivity and lack of activity could lead to changes in 
synaptic AMPAR properties. To fully define the selectivity of Arc that actually occurs in the 
brain, there is a requirement for the imaging of synaptic receptors in awake behaving 
animals. Due to technical limitations this is currently not possible. However in recent years 
there have been substantial technical developments which increase the resolution in the 
visualisation of synaptic AMPAR subunit trafficking. Therefore, to show whether Arc targets 
specific AMPAR subunits for endocytosis, fluorescent tagged Arc could be overexpressed 
using neuron-specific lentiviral vectors in vivo and then combined with fluorescent chemical 
compounds to label endogenous surface AMPAR subunits in acute slices [56, 57]. This 
approach combined with high-performance/resolution live imaging techniques [58, 59] would 
allow addressing whether Arc selectively targets specific AMPAR subunits to be internalised. 
This approach could also be used in combination with measurement of rectification of 
AMPAR-mediated mEPSCs amplitudes in acutely isolated slices (with Arc overexpressing 
neurons identified by fluorescence). These approaches would determine whether or not Arc 
selectively targets specific AMPAR subunits for endocytosis. 
 
3. The Arc-dependent endocytic pathway as a potential therapeutic target  
Many neurological and neurodegenerative diseases including autism [60], Rett syndrome 
[61], schizophrenia [62] depression [63], epilepsy [64-66] and Alzheimer’s disease [67] are 
associated with deficits in synaptic transmission and in particular, abnormalities in the 
trafficking of synaptic AMPAR. Defects in Arc function may underlie some of the observed 
changes in synaptic AMPAR trafficking and expression. For example, Arc probably plays a 
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role in the synaptic changes that occur in epilepsy, as Arc is strongly induced by seizure 
activity [68] (and that is how it was originally discovered [69]). It is tempting to link the many 
reports of increased forgetfulness in epileptic patients [70, 71] with enhanced AMPA receptor 
endocytosis in the hippocampus that presumably follow seizure-induced Arc expression, 
although there is currently no direct evidence for such a link. Disturbances in Arc induction 
may also play a role in the development of a range of neuropsychiatric disorders through 
changes in the transcription factors that activate the Arc gene. For example, synaptic activity 
induces the activation of the Myocyte Enhancer Factor 2 (MEF2) family of transcription 
factors resulting in the activation of a number of genes including Arc and the selective 
elimination of glutamatergic synapses onto hippocampal and striatal neurons [72-76]. The 
RNA binding protein, Fragile X Mental Retardation Protein (FMRP) is required for MEF2-
triggered synapse elimination [74, 76] along with the activation of metabotropic glutamate 
receptor 5 (mGluR5) on the dendrites of hippocampal CA1 neurons. Loss of function 
mutations in FMR1, MEF2c are linked with intellectual disability, autism and/or schizophrenia 
[77, 78]. Deficits in MEF2-induced synapse elimination that occur in Fragile X Syndrome 
models are likely to lead to the observed increase in dendritic spine density and deficits in 
experience-dependent spine elimination onto cortical neurons [79, 80]. Abnormal removal of 
Arc protein appears to occur in Angelman syndrome, a genetic disorder producing severe 
physical and intellectual disability. In a mouse model of Angelman syndrome there is 
enhanced AMPAR endocytosis leading to a decrease in hippocampal synaptic AMPARs 
[49]. The excessive internalization of AMPARs is likely to result from the failure to 
ubiquitinate and degrade Arc, due to the deficiency of Ube3A (an ubiquitin-protein ligase). 
Other Ube3A substrates, in addition to Arc, also probably contribute to the development of 
neurological disturbances. In Alzheimer’s disease (AD) patients it has been reported that Arc 
expression levels are significantly increased in the prefrontal cortex [67]. In a mouse model 
of AD (APP/PS1) there is a disruption in patterned Arc expression with expression reduced 
in some neurons but greatly overexpressed in other neurons [81]. These effects would be 
predicted to lead to abnormal levels of endocytosis of AMPAR subunits and these have 
indeed been reported [67, 82-84]. However, the precise GluA subunits that are internalised 
in these AD models remain contentious. 
A possible therapeutic intervention for diseases where AMPAR expression is abnormal is the 
manipulation of the Arc-CME pathway, in an attempt to normalise AMPAR subunit 
expression. The key position of Arc in the control of both synaptic strength and the 
composition of synaptic receptors together with its restricted expression (in neurons) makes 
it a strong candidate for such manipulation. In contrast, the ubiquitous nature of the CME 
pathway makes it a less favourable target; with for example mutations in endophilin and 
dynamin leading to disruptions in synaptic transmission [85, 86] and AP-2 null mutations in 
mice are lethal [87]. It is possible that additional proteins that have yet to be identified link 
Arc to the CME pathway and the internalisation of AMPAR subunits and these proteins may 
be useful therapeutic targets. It is also important to identify which AMPAR subunits are 
internalised by Arc, as this will determine the changes in synaptic receptor compositions 
produced by Arc manipulation. Thus it is important to fully define the Arc-CME pathway and 
to determine which AMPAR subunits are internalised through Arc induction.  This research 
highlights the importance of basic science to fully understanding signalling pathways in 
healthy conditions which then identifies targets for therapeutic intervention in pathological 
states.   
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Figure Legends  
 
Fig 1. Arc binds to AP-2 and endophilin/dynamin to facilitate AMPAR endocytosis.  
A proposed model of the mechanism by which Arc interacts with the clathrin mediated 
endocytosis (CME) pathway to facilitate AMPAR endocytosis. An increase in neuronal 
activity (or exposure to BDNF) promotes rapid Arc mRNA translation and protein expression 
at the dendritic spines. (1) Newly expressed Arc binds to the AP-2 complex, which binds 
directly or indirectly to AMPAR subunits at the plasma membrane. The identity of these GluA 
subunits is still open to debate and is discussed in details in the review. To initiate the 
formation of the clathrin-coated assembly AP-2 also binds and recruits clathrin to the 
membrane. Once formation of the pit is initiated, the binding affinity between Arc and AP-2 is 
reduced and Arc dissociates from AP-2. (3) Arc is then available to bind and recruit dynamin 
and endophilin to promote scission of the endocytic vesicle containing the AMPAR to then 
be targeted for either recycling or degradation (4). Please note that AP-2 and dynamin bind 
to Arc at the same motif [19, 23], therefore it is likely that Arc first binds to AP-2 and then 
binds to dynamin. Endophilin binds Arc at a different motif which allows it to bind to Arc at 
any time during the CME temporal sequence of events. Although this model fits the available 
data, additional experiments are required to either confirm or refute it.  
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Fig 2. Arc-facilitates endocytosis of GluA1 subunits and increases the rectification 
index. 
(A,B) Representative blots showing that Arc(WT), but not the Arc(W197A) mutant (that is unable 
bind to AP-2), facilitates GluA1, but not GluA2 endocytosis in H4 neuroglioma cells 
expressing myc-GluA1 (A) or myc-GluA2 (B) in combination with either: empty pCIneo 
vector, pCIneo Arc(WT) or pCIneo Arc(W197A). Western blot band densitometry analysis 
showing that: (a) Arc(WT), but not Arc(W197A),  promotes a significant reduction in surface 
expression of GluA1 subunits. However expression of either Arc(WT) or Arc(W197A) does not 
promote any changes in surface expression of GluA2 subunits(from daSilva et al., 2016; 
[23]). (C-E) Schematic panels constructed to illustrate the difference in rectification 
properties between AMPAR containing GluA2 subunits (blue) and those lacking GluA2 
subunits (red). (C) Current-voltage relationship for AMPAR-mediated currents, relative to the 
AMPAR-mediated current recorded at -60 mV and at a range of holding potentials from -60 
mV to +40 mV. Receptors which contain GluA2 have a linear current-voltage relationship 
whereas receptors lacking GluA2 show rectification when the cell is hold at positive 
potentials. (D) AMPAR-mediated mEPSC waveforms recorded at -60 mV and at + 40 mV for 
AMPAR containing GluA2 subunits (blue) and in those lacking GluA2 subunits (red). The 
mEPSCs produced by AMPAR lacking GluA2 subunits show rectification (smaller amplitude 
of mEPSCs at positive holding potentials). (E) Graph plotting the rectification index 
(amplitude at +40 mV/ amplitude at -60 mV) for the mEPSCs in (D). The rectification index 
for mEPSCs produced by AMPAR lacking GluA2 is smaller (shows more rectification) than 
for mEPSCs produced by AMPAR containing GluA2. (F) Representative average mEPSC 
waveforms recorded at a holding potential of -60 and + 40 mV for cells expressing GFP, 
Arc(WT) and Arc(W197A) in the presence of spermine (100 µM) in the intracellular solution. (G) 
Bar chart plotting the mean rectification index (peak amplitude at + 40 mV divided by peak 
amplitude at -60 mV) for neurons expressing GFP, Arc(WT) and Arc(W197A);. Note that Arc(WT) 
reduces the amount of rectification (as seen as an increase in the rectification index) 
whereas Arc(W197A) has significantly less effect on rectification, suggesting that Arc 
preferentially targets GluA1 for endocytosis (from da Silva et al., 2016; [23]). 
 
